The ISPE 2016 Process Validation Statistics Conference is in its 3rd year, continuing with its successful tradition of bringing together pharmaceutical leaders within the industry and regulatory authorities to share their thoughts in the implementation of the lifecycle approach to process validation. The keynote talks are always inspiring – and this year is no exception:
The ISPE 2016 Process Validation Statistics Conference will feature:
As always, there will be a mixed group of statisticians and process validation practitioners, representing every category of pharmaceutical manufacturing (small molecule, large molecule, devices, and more). For those of you who are not statisticians but want to know more about the statistics used in process validation and be better prepared for the conference sessions? There will be two 90-minute session on the first day of the conference to make you become better acquainted with some of the key topics that will be discussed during the sessions:
Learn more and register for the ISPE 2016 Process Validation Statistics Conference to be held on 25 – 27 October in Bethesda, MD USA, and bring your colleagues with you!
The following blog post was provided by Peyton Myers, an undergraduate student at Appalachian State University. Myers attended the 2023 ISPE Annual Meeting & Expo in Las Vegas as an ISPE Foundation Professional Development Grant recipient.
The integration of data science in biopharmaceutical manufacturing, emphasizing data quality, tech transfer efficiency, and process optimization, is the heart of this track. Led by industry experts, discussions explore leveraging digital twins, predictive analytics, and continuous improvement initiatives. Additionally, interactive roundtable discussions provide attendees with a dynamic forum...
The pharmaceutical sector stands at a crossroads of immense possibilities. We are witnessing an unprecedented surge in innovation, fueled by a remarkable partnership between industry and regulatory authorities. For example, there are initiatives fostered by the US Food and Drug Administration (US FDA) to promote innovation with programs such as CATT (CBER Advanced Technologies Team) and ETP...